Previous close | 40.39 |
Open | 40.54 |
Bid | 40.18 x 3200 |
Ask | 40.20 x 3000 |
Day's range | 39.97 - 40.62 |
52-week range | 39.23 - 56.32 |
Volume | |
Avg. volume | 23,118,691 |
Market cap | 225.767B |
Beta (5Y monthly) | 0.58 |
PE ratio (TTM) | 23.56 |
EPS (TTM) | 1.71 |
Earnings date | 01 May 2023 - 05 May 2023 |
Forward dividend & yield | 1.64 (3.76%) |
Ex-dividend date | 26 Jan 2023 |
1y target est | 52.81 |
In the latest trading session, Pfizer (PFE) closed at $40.22, marking a -0.42% move from the previous day.
Whether it's bear markets, shifting legislation, or an unstable macroeconomic environment, there are plenty of reasons an otherwise-stable company might see its stock stumble temporarily. Pfizer's (NYSE: PFE) shares are down by 20.3% in the last 12 months, and if you're willing to hold on to them for the long run, this stock is a great option for buying on the dip to gain a passive income stream.
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.